VistaGen Therapeutics clinical trials we track

Check company identity source

Phase 3 5 trials

Phase 2 2 trials

Drugs in these trials

Names as written in the registry records.

Latest recorded trial changes

Filters
Clear filters

· 5 fields changed

Participant count type changed

Before: Estimated. After: Actual.

Enrollment · participant count changed

Before: 60 participants (planned). After: 61 participants (actual).

Completion date type changed

Before: Estimated. After: Actual.

Primary completion date changed

Before: Apr 2026. After: 12 Jun 2026.

Recruitment status changed

Before: Recruiting. After: Completed.

Check registry source

· 5 fields changed

Participant count type changed

Before: Estimated. After: Actual.

Enrollment · participant count changed

Before: 236 participants (planned). After: 238 participants (actual).

Completion date type changed

Before: Estimated. After: Actual.

Primary completion date changed

Before: Apr 2026. After: 21 Apr 2026.

Recruitment status changed

Before: Recruiting. After: Active not recruiting.

Check registry source
PH94B in the Treatment of Adjustment Disorder With Anxiety

NCT04404192 · VistaGen Therapeutics, Inc.

· 1 field changed

Main study measure wording changed

Text changed; whether the study measures changed has not been verified. Saved text may be shortened.

Before: Measure: Hamilton Anxiety Scale. After: Measure: Hamilton Anxiety Scale (HAM-A) Score.

Check registry source

· 5 fields changed

Participant count type changed

Before: Estimated. After: Actual.

Enrollment · participant count changed

Before: 236 participants (planned). After: 238 participants (actual).

Completion date type changed

Before: Estimated. After: Actual.

Primary completion date changed

Before: Oct 2025. After: 31 Oct 2025.

Recruitment status changed

Before: Recruiting. After: Active not recruiting.

Check registry source